Background: Atopic dermatitis (AD) represents the most common inflammatory skin
| INTRODUCTION
Atopic dermatitis (AD) is the most common relapsing inflammatory skin disease affecting about 10%-20% of children and 1%-3% of adults worldwide. AD phenotypes are characterized by cutaneous hypersensitivity to environmental triggers through IgE-mediated sensitization, skin barrier dysfunction and immune dysregulation. 1 Its prevalence is largely dependent on multiple factors, including genetic and environmental factors such as pollutants and industrialization. So far, various genetic factors including single nucleotide polymorphisms or mutations have been associated with AD. Particularly, FLG mutations are found in up to 50% of patients with AD, indicating that dysregulated FLG expression represents a major predisposing factor for a dysfunctional epithelial barrier in the pathogenesis of AD. 2, 3 Another important factor involved in the disruption of the epidermal barrier or in immune dysfunction is the colonization by Staphylococcus aureus. This infection represents a common feature of moderate to severe AD, showing overexpansion in more than 90%
of patients with AD. [4] [5] [6] In a birth cohort study, the colonization by S. aureus during the first 2 years of life was associated with the clinical onset of AD, 7 implying that skin colonization by S. aureus may represent an important causal factor for AD development. In fact,
S. aureus has been associated with the pathogenesis of AD, as it secretes enterotoxins, antigens and proteases that lead to the dysregulation of skin homeostasis by affecting keratinocytes and various immune cells. 8 Recently, gram-positive bacteria including S. aureus have been shown to release extracellular vesicles (EVs) called membrane vesicles. 9, 10 Similar to the outer membrane vesicles of gram-negative bacteria, gram-positive bacteria-derived EVs are lipid bilayer-enclosed spherical vesicles of~100 nm in diameter. 9, 11 These can mediate pathophysiological functions by inducing cellular inflammation and evoking host cell death. [12] [13] [14] [15] In particular, the application of S. aureus-derived EVs (SEVs) to tape-stripped mouse skin resulted in AD-like inflammation in the absence of live bacterial cells. 12, 16, 17 Moreover, SEV-specific IgE serum levels were significantly increased in patients with AD, 12 suggesting that SEVs can evoke immune responses and promote AD; however, the molecular mechanism underlying SEV-mediated inflammatory responses remains unclear.
A prominent perivascular infiltrate containing immune cells represents another hallmark of AD during the acute and chronic phases. 4 Moreover, microvascular endothelial cells participate in the host's innate immune response by expressing specific cytokines and cell adhesion molecules. This occurs through the cytokine cascade and therefore activates and subsequently increases the adherence of leucocytes to the endothelium and their movements towards extravascular tissues. [18] [19] [20] [21] Considering that S. aureus colonizes the epidermis and produces EVs that access the endothelium, we hypothesized that SEVs might directly stimulate microvascular endothelial cells and contribute to the pathogenesis of AD.
Here, we evaluated the ability of SEVs as proinflammatory factors to activate human dermal microvascular endothelial cells (HDMECs) and recruit human monocytic THP-1 cells. We found that 
| Cell culture
Human dermal microvascular endothelial cells (C-12210), derived from juvenile foreskin, were purchased from PromoCell GmbH (Heidelberg, Germany) and grown in Endothelial Cell Growth Medium MV2 (PromoCell GmbH) supplemented with 1% or 5% fetal calf serum and SupplementMix (C-39225; PromoCell GmbH) at 37°C in a humidified incubator (5% CO 2 ). Human monocytic cell line THP-1 was purchased from ATCC (ATCC TIB-202 ; Manassas, VA) and cultured in RPMI 1640 with or without phenol red media supplemented with 10% fetal bovine serum, 100 U/mL of penicillin and 100 μg/mL of streptomycin at 37°C in a 5% CO 2 incubator. 
| Isolation of gram-positive bacterial EVs

| Analysis and labelling of S. aureus-derived EVs
The size and distribution of SEVs were measured by dynamic light scattering using a Zetasizer Nano ZS (Malvern Instruments Limited, Malvern, UK) and analysed using the Dynamic V6 software. An average of three measurements was used. Isolated SEVs were labelled with 5 μmol/L DiI dye (1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate; Molecular Probes, Eugene, OR) for 30 minutes at 37°C and then purified by density-gradient ultracentrifugation, as described in Supporting information.
HDMECs were treated with DiI-labelled SEVs with or without endocytic inhibitors for 1 or 3 hours, and the DiI signal was analysed under a confocal microscope (LSM 700; Carl Zeiss, Jena, Germany). Confocal images were converted to JPG format using an image software (Zen 2.3; Carl Zeiss MicroImaging GHBH, Jena, Germany). The signal intensity of fluorescence images was processed consistently by adjusting each image with brightness +40%
and contrast 0% ( Figure 1B ) or brightness +20% and contrast +20% ( Figure 2E ).
| qRT-PCR analysis
Total RNAs were extracted using TRIzol (Invitrogen, Carlsbad, CA), and cDNA was synthesized using a Revertaid RT kit (Thermo Fisher Scientific) according to the manufacturer's instructions.
qRT-PCR was performed using specific TaqMan probes and the 7500 Fast Real-Time PCR system (Applied Biosystems, Foster City, CA). Gene expression was determined using the 2 ÀΔΔCt method, and all data were normalized to glyceraldehyde 3-phosphate dehydrogenase.
| Western blot analysis
Human dermal microvascular endothelial cells were lysed in RIPA buffer containing a phosphatase inhibitor cocktail (Roche, Basel, Switzerland). After centrifugation at 15 700×g for 10 minutes at 4°C, the supernatant was loaded onto a NuPAGE ™ 4%-12% Bis-Tris Gel, and the protein bands were visualized using the Amersham Imager 600 system (GE Healthcare, Chicago, IL).
| Monocyte adhesion assay
The adhesion of THP-1 cells to HDMECs was assessed as previously described. 24 Bethesda, MD, USA). The IL-6 levels in the culture supernatants were determined using a specific human ELISA kit for IL-6 (R&D Systems). To examine the effect of endocytic inhibitors on IL-6 levels, HDMECs were treated with 100 ng/mL SEVs in the presence of 10 μg/mL chlorpromazine, 10 μg/mL nystatin or DMSO for 6 hours.
| siRNA transfection
Human dermal microvascular endothelial cells were transfected with siRNAs targeting human p65 (SMARTpool siRNA; Dharmacon Inc., Lafayette, CO) or human TLR4 or a non-targeting control siRNA using a Lipofectamine ™ RNAiMAX kit (Thermo Fisher Scientific) according to the manufacturer's instructions.
| Statistical analysis
The data were analysed using the Student's t test and expressed as the mean ± standard deviation (SD). All experiments were performed at least three times, and representative results are shown. 
| S. aureus-derived EVs increased the expression of cell adhesion molecules in HDMECs
To test whether SEVs contribute to the perivascular infiltration of immune cells by directly stimulating HDMECs, we first isolated SEVs from S. aureus culture supernatants using a previously described combinational centrifugation method 9 and analysed the size and distribution of SEVs using dynamic light scattering. The isolated SEVs had an average diameter of 186.6 ± 6.255 nm, although the average diameter of the main clusters appeared to be less than 100 nm ( Fig To further investigate the upregulation of cell adhesion molecules on HDMECs following SEV treatment, we performed a monocyte recruitment assay using the fluorescently labelled human monocytic cell line THP-1. Whereas the recruitment of monocytes is considered essential for the effective clearance of various infections, recruited monocytes also contribute to the pathogenesis of inflammatory disorders. 25 We 
| SEVs increased the expression of the IL-6 proinflammatory cytokine in HDMECs
We further investigated whether SEVs can induce the release of inflammatory cytokines, most of which are released from skin and immune cells upon S. aureus infection. 12, 15, 26 We performed a cytokine array analysis using conditioned media from HDMECs at 6 hours post-SEV treatment. Among 42 analysed cytokines, only four, that is, GRO a/b/g, GM-CSF, IL-6, and EGF, were upregulated in SEV-treated HDMECs when compared to the vehicle-or PEV-treated groups; in particular, IL-6 expression exhibited the largest increase following SEV administration (Figure 2A,B) . The F I G U R E 2 Staphylococcus aureus-derived extracellular vesicles increase the expression of IL-6 in HDMECs. HDMECs were treated with Propionibacterium acnes-derived EVs (PEVs) or SEVs for 6 h, and the culture supernatants were analysed using a cytokine array and an ELISA kit for IL-6. A, Cytokine array analysis. Red boxes denote the cytokines that were increased in SEV-treated cells compared to vehicle (HBS)-or PEV-treated groups. B, Denoted spots on the blot were analysed using densitometry. C, The secreted IL-6 protein levels were assessed in culture supernatants of SEV-treated HDMECs using an ELISA kit. The data are expressed as the mean ± SD of three independent experiments (***P < 0.001 compared to vehicle control). Veh, HBS-treated. D, SEVs were used to treat HDMECs supplemented with vehicle (HBS), 10 μg/ mL chlorpromazine (CPZ), 10 μg/mL nystatin (NYS) or DMSO for 6 h. The secreted IL-6 protein levels were determined using an IL-6 ELISA kit. The data are expressed as the mean ± SD of four samples from two biological replicates (***P < 0.001; **P < 0.05). E, The DiI-labelled SEVs were used to treat HDMECs for 3 h. The DiI signal (red) and DAPI (blue) were observed under confocal microscopy. Veh, HBS-treated. Scale bar, 10 μm HDMECs were transfected with scrambled control (SC) or TLR4 siRNAs (siTLR4) for 48 h and then treated with SEVs (100 ng/ mL) for an additional 6 h. The mRNA (A, C) and protein expression levels (B, D) of Eselectin, ICAM1, VCAM and IL-6 were determined using qRT-PCR or Western blotting, using the respective primers or antibodies and an ELISA kit for IL-6. The data are expressed as the mean ± SD of three independent experiments (***P < 0.001) molecules such as E-selectin and ICAM1 appeared not to be affected by the TLR4 knockdown. These results suggested that SEVs, as potent proinflammatory factors, trigger a more rapid and intense induction of cell adhesion molecules and inflammatory cytokines than S. aureus extracts in HDMECs and could contribute to the infiltration of immune cells in hyperinflammatory skin disorders, such as AD.
| DISCUSSION
While SEV-mediated responses in immune cells and keratinocytes have been previously investigated, 15 the effects of SEVs on endothelial cells remain unclear. We demonstrated that SEVs activate HDMECs rapidly and effectively by increasing the expression of
Staphylococcus aureusderived extracellular vesicles induce the activation of HDMECs via the NF-κB signalling pathway. A, Total or phosphorylated protein levels for p65 (p65 vs P-p65) and JNK (JNK vs P-JNK), and adhesion molecules in HDMECs treated with SEVs (100 ng/mL) and harvested at the indicated time-points. B, C, Protein levels of adhesion molecules (B) and IL-6 (C) in HDMECs pretreated with inhibitors for 1 h and incubated with SEV (100 ng/ mL) for an additional 6 h. Veh, HBStreated; -, DMSO-treated; BAY, BAY 11-7082; SP, SP600125. D, E, Protein levels of adhesion molecules (D) and IL-6 (E) in HDMECs transfected with scrambled control (SC) or p65 siRNAs (sip65) for 48 h and treated with SEV (100 ng/mL) for 6 h. β-actin was used as a loading control. Data in (C) and (E) are expressed as the mean ± SD of three independent experiments (***P < 0.001) cell adhesion molecules and inflammatory cytokines through TLR4-NF-κB signalling and subsequently induce monocyte adherence to HDMECs ( Figure 6D ). Thus, to our knowledge, this is the first report demonstrating the direct effects of SEVs on the human dermal microvascular endothelium.
Staphylococcus aureus is a representative pathogenic microorganism that is closely associated with the onset and progression of AD. 4, 7 Accordingly, antibiotic therapy is prescribed for patients with AD; however, this is less effective because of the re-colonization with the same toxin-secreting organism when drugs are no longer prescribed, the emergence of antibiotic-resistant strains, or the disturbance of beneficial commensal microbiomes. 5, 26, 33 Therefore, alternative therapeutic strategies have been developed to regulate rather than eradicate microbes in patients with AD using specific monoclonal antibodies against virulent toxins, vaccines, probiotics or substances derived thereof.
Several S. aureus-derived factors have been speculated to be involved in immune responses and AD phenotypes including superantigen, staphylococcal enterotoxin B, staphylococcal alpha toxin (α-hemolysin), lipoteichoic acid, peptidoglycan and staphylococcal protein A (SPA). [34] [35] [36] [37] [38] [39] [40] [41] However, SPA or superantigen did not show any significant correlation with skin inflammation or severity of AD, 42, 43 suggesting that there is a molecular complex in S. aureus-mediated AD pathogenesis. In addition to virulence-associated factors, S. aureus spontaneously releases EVs. SEVs have been considered as a potent vehicle that deliver such virulent factors to the epidermis. Based on proteomic analysis, SEVs contain more than 100 proteins including α-hemolysin, SPA and β-lactamases. 9 Recently, it was reported that EVs derived from gram-negative bacteria essentially deliver lipopolysaccharide into the cytosol via endocytosis and trigger caspase-11 activation, 44 suggesting that EV-associated pathogen-associated molecular 
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